Removal of inflammatory cytokines and endotoxin by veno-venous continuous renal replacement therapy for burned patients with sepsis

被引:115
作者
Peng, YZ [1 ]
Yuan, ZQ [1 ]
Li, HB [1 ]
机构
[1] Third Mil Med Univ, Inst Burn Res, SW Hosp, Chongqing 400038, Peoples R China
关键词
continuous renal replacement therapy; burn; sepsis; endotoxin; cytokine; inflammatory;
D O I
10.1016/j.burns.2005.02.004
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To evaluate the effect of veno-venous continuous renal replacement therapy (CRRT) on the plasma levels of endotoxin and cytokines in severely burned patients with sepsis. Methods: Twenty adult severely burned patients with sepsis were studied. For the diagnosis of sepsis, patients were randomly divided into CRRT (n = 10) and Control (it = 10). Both groups received conventional therapy after admission. Veno-venous CRRT was administered to 10 patients in the CRRT group whenever patients were determined to be septic. The plasma level of endotoxin, TNF-alpha, IL-1 beta, IL-6 and IL-8 were measured at 0, 1, 2, 6, t2, 36 and 60 h after CRRT initiation, and at 0, 12, 36 and 60 h after the patients were diagnosed as having sepsis in the Control group. Main Results: Plasma level of endotoxin and all the cytokines after CRRT initiation were significantly lower than those before the treatment (P < 0.01). The serial change of endotoxin, IL-1 beta, IL-6 and IL-8 was significantly lower at 12, 36 and 60 h after treatment compared with Control groups (P < 0.01). A significant decrease in plasma TNF-alpha levels was seen at 36 and 60 h after treatment compared with Control groups (P < 0.01). Conclusion: Plasma endotoxin and cytokines (TNF-alpha, IL-1 beta, IL-6 and IL-8) can be removed effectively with CRRT in severely burned patients with sepsis. (C) 2005 Elsevier Ltd and ISBI. All rights reserved.
引用
收藏
页码:623 / 628
页数:6
相关论文
共 21 条
[1]   Why immunomodulatory therapies have not worked in sepsis [J].
Abraham, E .
INTENSIVE CARE MEDICINE, 1999, 25 (06) :556-566
[2]   TREATMENT OF SEPSIS BY EXTRACORPOREAL ELIMINATION OF ENDOTOXIN USING POLYMYXIN B-IMMOBILIZED FIBER [J].
AOKI, H ;
KODAMA, M ;
TANI, T ;
HANASAWA, K .
AMERICAN JOURNAL OF SURGERY, 1994, 167 (04) :412-417
[3]   CONTINUOUS VENOVENOUS HEMOFILTRATION WITH DIALYSIS REMOVES CYTOKINES FROM THE CIRCULATION OF SEPTIC PATIENTS [J].
BELLOMO, R ;
TIPPING, P ;
BOYCE, N .
CRITICAL CARE MEDICINE, 1993, 21 (04) :522-526
[4]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[5]   The physiologic basis for anticytokine clinical trials in the treatment of sepsis [J].
Cain, BS ;
Meldrum, DR ;
Harken, AH ;
McIntyre, RC .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 186 (03) :337-350
[6]  
De Vriese AS, 1999, J AM SOC NEPHROL, V10, P846
[7]   Development of a continuous renal replacement program in critically ill patients [J].
Gilbert, RW ;
Caruso, DM ;
Foster, KN ;
Canulla, MV ;
Nelson, ML ;
Gilbert, EA .
AMERICAN JOURNAL OF SURGERY, 2002, 184 (06) :526-532
[8]   Extracorporeal treatment for septic patients: New adsorption technologies and their clinical application [J].
Hanasawa, K .
THERAPEUTIC APHERESIS, 2002, 6 (04) :290-295
[9]   Continuous haemofiltration and haemodiafiltration for acute renal failure in severely burned patients [J].
Leblanc, M ;
Thibeault, Y ;
Querin, S .
BURNS, 1997, 23 (02) :160-165
[10]   Continuous renal replacement therapies: An update [J].
Manns, M ;
Sigler, MH ;
Teehan, BP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (02) :185-207